Large-scale testing (Phase 3)Looking for participantsNCT06750094
What this trial is testing
Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Who this might be right for
Colorectal Neoplasms
Janssen Research & Development, LLC 700